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Background Keratolysis exfoliativa (KE), also known as dyshidrosis lamellosa sicca,
is a palmoplantar dermatosis characterized by air-filled blisters and collarette des-
quamation. It has been regarded as a subtype of dyshidrotic eczema, a fungal
infection or a dermatophytid reaction. KE may also resemble acral peeling skin
syndrome and localized epidermolysis bullosa simplex. Although KE is a common
disorder, it is a rarely reported and is an under-recognized dermatosis.
Objectives To delineate the characteristic features of KE.
Methods We investigated the clinical, immunohistopathological, ultrastructural and
molecular features of KE. Patients were included from the clinical records. Addi-
tional diagnostic research consisted of mutation analysis of the candidate genes
TGM5, KRT5, KRT14, FLG, SPINK6 and SPINK9.
Results A total of 24 patients with KE were identified, six with familial and 18 with
sporadic KE. Lesions consisted of air-filled blisters only on palmoplantar skin, fol-
lowed by collarette and lamellar peeling. Both light microscopy and electron
microscopy showed cleavage and partially degraded corneodesmosomes within the
stratum corneum, whereas immunofluorescence microscopy showed normal
expression of corneodesmosomal components. No mutations were found in TGM5,
KRT5 ⁄14 and SPINK6 ⁄9. There was no clear link with atopy or with FLG mutations.
Conclusions Our study suggests premature corneodesmolysis as the main pathologi-
cal mechanism of this palmoplantar skin disorder. We conclude that KE appears
to be a distinct peeling entity.
Keratolysis exfoliativa (KE) was first described by Caryon in
1903 under the name ‘desquamation estivale en aires des
mains’.1 In 1919, Wende reported the same condition and
called it ‘keratolysis exfoliativa’.2 Since 1947, it has also been
known as ‘dyshidrosis lamellosa sicca’ or ‘lamellar dyshidro-
sis’.3 The last two original publications on KE date back to
19504 and 19965; in the latter, the name ‘recurrent focal pal-
mar peeling’ was used.
KE affects only the volar aspects of the hands and feet. Typi-
cally it starts with an annular erythema with an air-filled blis-
ter arising in the centre, followed by superficial collarette and
lamellar peeling.3,4,6 In the more severe cases, multiple lesions
coalesce and this may result in superficial peeling of the entire
surface of the palmoplantar skin.7,8
Subjective symptoms are rare,5,6,8 although the skin can be
sensitive when it becomes thin from successive peeling.9,10
The condition worsens in warm weather and patients often
present with palmar and ⁄or plantar hyperhidrosis.9,11 No
effective treatments have yet been described.5
KE has been regarded as a subtype of acrovesicular dermatitis or
dyshidrotic eczema and associated with atopy.11,12 Moreover, it
has been proposed that KE is a fungal infection3 or a dermatophy-
tid reaction caused by interdigital dermatomycosis of the feet.8 KE
clinically also resembles acral peeling skin syndrome (APSS),
which is characterized by superficial exfoliation on the volar and
dorsal aspects of the hands and feet, caused by mutations in the
TGM5 gene.13 In addition, epidermolysis bullosa simplex (EBS) of
the hands and feet caused by mutations in either KRT5 or KRT14
and characterized by fluid-filled blisters on the volar and dorsal
aspects of the hands and feet can be mistaken for KE.14
Here we describe the clinical, immunohistopathological,
ultrastructural1 and molecular features of KE and we discuss a
possible pathological mechanism for this common, but
relatively underappreciated palmoplantar dermatosis.
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Materials and methods
Patients
Patients were enrolled from the specialized expertise centres
for blistering diseases and eczema of the academic dermatol-
ogy department in Groningen between 1988 and 2011. Eligi-
ble patients satisfied the criteria of recurrent, palmoplantar
air-filled blistering and peeling. These patients were
approached by letter or were referred to our clinic and all
completed a standardized questionnaire.
Clinical examination
The following clinical data were recorded in each patient: age,
age at onset, familial occurrence, morphology and localization
of the lesions, subjective symptoms, aggravating factors, pres-
ence of palmoplantar hyperhidrosis, history of atopy, history
of tinea pedis and response to treatments.
Additional diagnostic examinations
Serum levels of IgE specific to inhaled allergens were deter-
mined with the ImmunoCap method (Phadia ⁄Thermo Scien-
tific, Uppsala, Sweden). Also, potassium hydroxide (KOH)
preparation along with fungal and yeast culture of palmoplan-
tar scales were performed.
Molecular analyses
Genomic DNA was extracted from blood using the QIAamp
DNA Blood Maxi Kit (Qiagen, Venlo, the Netherlands). All ex-
ons and their flanking intronic regions of TGM5 and KRT5 ⁄14
were analysed as described by Cassidy et al.13 and Bolling
et al.,14 respectively. The four most prevalent FLG mutations,
i.e. R501X, 2282del4, S3247X and R2447X, were screened as
described by Sandilands et al.15 Polymerase chain reaction
(PCR) amplification of exons 1–4 of SPINK6 and exons 1–4 of
SPINK9 and their flanking intronic regions was performed. The
following primers (synthesized by Biolegio, Nijmegen, the
Netherlands) were used: SPINK6 exon 1, forward GAAACTTTA
GAAAGAAGAGCCG and reverse TTACCATAACCATTGTCGTC;
SPINK6 exon 2, forward TTTAAGATAGCCAAGTACCAGGAG
and reverse GTGAAGATCAAGCCAAGCAC; SPINK6 exon 3, for-
ward CACTGATGTCAATGTCACTC and reverse TTGTTTCTTC
AGTCTCTATGGG; SPINK6 exon 4, forward TGGTGAGTACTT
ACGATATTGC and reverse AGTAAGAACACAGTCAATGC;
SPINK9 exon 1, forward TATAAGGCAGGATCAAAGTGAG and
reverse TATCCCAGAATTACATAGGCAG; SPINK9 exon 2, for-
ward GTAAGATTAGGTTCTTCCAGAG and reverse AAAGTAG
GATGGGTGTACTG; SPINK9 exon 3, forward TTGGTTGAAA
GAGTTGAAGG and reverse CTGGAAGGTTCTGTTTGTTAGAG;
SPINK9 exon 4, forward TGGATGCTAATGAAATGCCT and
reverse TATCTATTAGACAGCACCCA. PCR products were elec-
trophoresed on a 1% agarose gel, and the bands were excised
and extracted from the agarose gel with the MinElute Gel
Extraction kit (Qiagen) and subsequently sequenced.
Skin biopsies
Four biopsies (IIIA, VIA, VII and VIIIA) solely for light
microscopy, seven biopsies (IA, IIA, IIIB, IV, V, IX and X) for
both electron microscopy and light microscopy, and four
biopsies (IB, IIB, VIB and VIIIB) for immunofluorescence
microscopy were included in this study (Table 1). Biopsies IA,
IIA, IIIA, IV, VIA, VII, VIIIA, IX and X were taken at the edge
of an air-filled blister and biopsies IB, IIB, IIIB, V, VIB and
VIIIB were taken from perilesional skin.
For light microscopy, the biopsies were fixed in 4% formal-
dehyde and embedded in paraffin. Then, semithin sections
were cut, stained with haematoxylin–eosin and examined with







LM EM + LM IF
1 59 ⁄M IA: edge of blister IB: perilesional Plantar aspect of left hallux (EM + LM);
plantar aspect of the left sole (IF)
5 36 ⁄M IIA: edge of blister IIB: perilesional Volar aspect of right thumb (EM + LM);
volar aspect of left thumb (IF)
6 40 ⁄M IIIA: edge of blister IIIB: perilesional Palmar aspect of right hand (LM); volar aspect
of right thumb (EM + LM)
7 32 ⁄F IV: edge of blister Volar aspect of right thumb
8 46 ⁄F V: perilesional Volar aspect of left third digit
11 46 ⁄M VIA: edge of blister VIB: perilesional Volar aspect of right second digit (LM + IF)
13 17 ⁄F VII: edge of blister Plantar aspect of left hallux
17 43 ⁄M VIIIA: edge of blister VIIIB: perilesional Volar aspect of left third digit (LM);
volar aspect of left thumb (IF)
23 19 ⁄F IX: edge of blister Plantar aspect of right sole
24 43 ⁄M X: edge of blister Volar aspect of left fifth digit
LM, light microscopy; EM, electron microscopy; IF, immunofluorescent microscopy.
 2012 The Authors
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a light microscope (Zeiss Axio Imager; Zeiss, Go¨ttingen, Ger-
many).
For electron microscopy, three biopsies (IV, IX and X) were
fixed by the standard protocol in 2% glutaraldehyde in
0Æ1 mol L)1 phosphate buffer and post-fixed with 1% osmium
tetroxide in 0Æ1 mol L)1 cacodylate buffer with 1Æ5% potas-
sium ferrocyanide. Then, the biopsies were dehydrated in
ethanol and embedded in Epon (Hexion Specialty Chemicals
Inc., Danbury, CT, U.S.A.). Semithin and ultrathin sections
were cut. For light microscopy, the semithin sections were
stained with toluidine blue–basic fuchsin. The ultrathin sec-
tions were stained with uranyl acetate and lead citrate, and
examined with a Philips CM100 transmission electron micro-
scope (Philips, Eindhoven, the Netherlands).
Four biopsies (IA, IIA, IIIB and V) and control skin were
fixed by an adjusted protocol to gain optimal preservation and
visualization of lipids and membranes in the stratum corneum.
These biopsies were fixed in 2% paraformaldehyde and 2%
glutaraldehyde in 0Æ1 mol L)1 cacodylate buffer. Then, the
biopsies were fixed with 1% osmium tetroxide in 0Æ1 mol L)1
cacodylate buffer and post-fixed with 0Æ5% ruthenium tetrox-
ide with 0Æ25% potassium ferrocyanide. The biopsies were
dehydrated in ethanol and embedded in Epon. Semithin and
ultrathin sections were cut. The semithin sections were stained
with toluidine blue and examined with a light microscope.
The ultrathin sections were stained and examined as described
in the standard protocol.
For immunofluorescence microscopy, four unfixed snap-
frozen biopsies of KE skin and a control skin sample were cut
in a cryostat into 6-lm sections. The sections were incubated
in a humidified chamber in the dark for 30 min at room tem-
perature with primary antibodies for corneodesmosin (Santa
Cruz, Heidelberg, Germany), desmocollin-1 (Progen Biotech-
nik, Heidelberg, Germany) and desmoglein-1 endodomain
and ectodomain (Santa Cruz and Progen Biotechnik, respec-
tively). After rinsing with PBS, the sections were incubated for
30 min with the secondary antibodies fluorescein-isothiocya-
nate-labelled rabbit antigoat IgG antibody (Invitrogen, Paisley,
U.K.) or Alexa568-labelled goat antimouse IgG antibody
(Dako, Enschede, the Netherlands). Images were recorded
using a Leica DMRA immunofluorescence microscope (Leica,
Heidelberg, Germany) with the same setting of contrast and
brightness in the control and patient sections.
Results
Patients and clinical assessment
A total of 24 patients were included. Patients 1–11, 17, 22 and
24 revisited our outpatient clinic and were clinically reassessed.
Data of patients 12–16, 18–21 and 23 were derived from
patient files. The clinical features of the patients with KE are
summarized in Table 2. Thirteen patients were male and 11
female, and the age ranged between 5 and 69 years with a med-
ian of 32 years. The age at onset ranged between 0 and 64 years
with a median of 19 years. Familial occurrence was present in
patients 1–6. Patients 1 and 2 were father and daughter, patients
3 and 4 were siblings, patient 5 reported that his mother had
similar lesions and patient 6 had a sister with similar lesions.
KE started with an erythematous ring (Fig. 1a), which was
observed at the time of consultation in 13 patients. Subse-
quently, a pale air-filled blister (Fig. 1b) developed within the
boundaries of the ring, of which the roof opened in the cen-
tre, followed by superficial centrifugal and collarette desqua-
mation (Fig. 1c) and, eventually, lamellar peeling in all
patients. The peeled areas could become susceptible to the de-
velopment of erosions, but were rarely erythematous and did
not contain any pinpoint vesicles. The condition appeared to
be recurrent and mostly subsided completely between each
cycle. The peeling occurred only on palms and ⁄or soles, and
spread to the lateral aspects of the fingers and ⁄or toes. The
fingers were most frequently involved (n = 18). Two patients
(5 and 20) had lesions only on the fingertips, and two others
(10 and 16) had lesions mainly on the tips of the fingers and
toes. The condition appeared to be symmetrical on hands
and ⁄or feet, except in one patient (no. 20) who had lesions
only on the fingers of his right hand. The severity of the peel-
ing varied between patients.
(a) (b)
(c)
Fig 1. Palmoplantar desquamation in keratolysis exfoliativa starts with
an erythematous ring (arrows) bordering collarette desquamation on
the volar aspect of the thumb (a), which changes to an air-filled
blister (b), and is followed by centrifugal, collarette peeling on the
palm and volar aspects of the fingers (c).
 2012 The Authors
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The peeling was preceded by slight pruritus in six patients,
and by mild burning sensation in five patients. Fifteen patients
reported pain when the skin became thin in the peeled areas,
and therefore susceptible to the development of erosions. Six
patients did not have any subjective symptoms. Aggravating
factors were warm weather (n = 12), friction (n = 11) and
water contact (n = 7). Five patients did not experience any
aggravating factors. Hyperhidrosis was present in 11 patients
(palmoplantar n = 5, palmar n = 3, plantar n = 3). None of
the patients experienced improvement of their lesions when
treated topically with indifferent compound ointments, kerato-
lytic urea, steroids or antifungals.





























BS, pain Warm weather,
friction
No hyperhidrosis






4b 9 ⁄F 8 + Air-filled blisters, peeling Soles, toes No symptoms Warm weather,
water contact
No hyperhidrosis
5c 36 ⁄M 30 + Erythematous ring,
air-filled blisters, peeling
Fingers Pain Warm weather,
water contact
No hyperhidrosis
6d 40 ⁄M 10 + Erythematous ring,
air-filled blisters, peeling








Pruritus, pain Warm weather,
water contact
Plantar




BS Friction No hyperhidrosis
9 62 ⁄F 56 ) Air-filled blisters, peeling Palms, fingers Pain Warm weather No hyperhidrosis
10 9 ⁄F 0 ) Air-filled blisters, peeling Palms, fingers,
toes
Pruritus, pain Water contact Palmoplantar




No symptoms Warm weather Palmoplantar
12 16 ⁄F 12 ) Erythematous ring,
air-filled blisters, peeling
Soles, toes BS Friction Palmoplantar
13 17 ⁄F 11 ) Erythematous ring,
air-filled blisters, peeling
Soles, toes Pain Friction No hyperhidrosis
14 69 ⁄M 64 ) Air-filled blisters, peeling Palms, fingers,
soles, toes
Pruritus No aggravation Palmar
15 5 ⁄M 1Æ5 ) Erythematous ring,
air-filled blisters, peeling
Soles No symptoms No aggravation No hyperhidrosis
16 10 ⁄M 7Æ5 ) Air-filled blisters, peeling Fingers, soles,
toes
No symptoms No aggravation Plantar
17 43 ⁄M 27 ) Erythematous ring,
air-filled blisters, peeling
Palms, fingers Pruritus, pain Warm weather No hyperhidrosis
18 49 ⁄M 43 ) Air-filled blisters, peeling Palms, soles No symptoms No aggravation No hyperhidrosis
19 52 ⁄M 45 ) Air-filled blisters, peeling Palms, fingers Pruritus, pain Friction No hyperhidrosis
20 32 ⁄M 30 ) Erythematous ring,
air-filled blisters, peeling
Fingers Pain No aggravation No hyperhidrosis
21 32 ⁄F 29 ) Erythematous ring,
air-filled blisters, peeling
Fingers, toes Pain Warm weather Palmar
22 13 ⁄M 12 ) Air-filled blisters, peeling Palms, fingers Pain Friction Palmar
23 19 ⁄F 10 ) Air-filled blisters, peeling Soles, toes No symptoms Friction No hyperhidrosis
24 43 ⁄M 24 ) Air-filled blisters, peeling Palms, fingers,
soles, toes
Pruritus, pain Friction, warm
weather
No hyperhidrosis
FO, familial occurrence; +, positive; ), negative; BS, burning sensation. aPatients 1 and 2 are father and daughter. bPatients 3 and 4 are sib-
lings. cPatient 5 reported that his mother had similar lesions. dPatient 6 has a sister with similar lesions.
 2012 The Authors
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Ten of the 24 patients had a history of ‘atopic’ diseases,
although only three of 13 had elevated serum levels of aller-
gen-specific IgE (Table 3). Two of the 24 patients had a posi-
tive history of tinea pedis, but KOH preparations along with
cultures of palmoplantar scales were negative. Moreover, KOH
preparations and cultures of palmar and ⁄or plantar scales in
11 other patients were also negative (Table 3).
Histopathological and ultrastructural analysis
Light microscopy of the nine biopsies taken at the edge of an
air-filled blister (IA, IIA, IIIA, IV, VIA, VII, VIIIA, IX and X;
see Table 1) all showed cleavage within the stratum corneum
(Fig. 2a). The level of the cleavage varied between biopsies in
the upper, mid or lower part of the stratum corneum. Paraker-
atosis with a thinned stratum granulosum was found in five of
the 11 biopsies (IIIA, IIIB, IV, VIA and VIIIA) (Fig. 2b). None
of the 11 studied biopsies demonstrated an inflammatory infil-
trate, exocytosis of lymphocytes or acanthosis.
Electron microscopy of control skin and of all seven KE skin
biopsies (IA, IIA, IIIB, IV, V, IX and X) showed physiologi-
cally partially degraded corneodesmosomes at the stratum cor-
neum surface where the outermost corneocytes begin to
desquamate. However, in three (IA, IIA and IIIB) of the seven
KE biopsies, degradation of corneodesmosomes with intercel-
lular widening was also observed lower in the stratum corne-
um just above and below the cleft in biopsies taken at the
edge of an air-filled blister (IA and IIA) (Fig. 2c), and in the
mid part of the stratum corneum in unclefted perilesional skin
(IIIB) (Fig. 2d). None of the samples showed other ultrastruc-
tural abnormalities in the basal, spinous or granular epidermal
layer.
Immunofluorescence microscopy showed similar expression
of corneodesmosin, desmocollin-1 and desmoglein-1, both
endodomain and ectodomain, in all four KE skin biopsies,
compared with the control skin (Fig. 3).
No mutations in ﬁve candidate genes for keratolysis
exfoliativa
As the KE phenotype often resembles APSS and EBS, molecular
analysis was performed to investigate if KE could also be
caused by mutations in TGM5, a gene coding for the transglu-
taminase 5 protein, or the genes encoding keratin 5 or 14
(KRT5 ⁄14). We analysed the TGM5 gene in nine patients, and
the KRT5 ⁄14 genes in two doubtful patients. We also screened
for FLG mutations and found in one (no. 6) of 16 tested
patients the prevalent R501X mutation heterozygously present,
thus confirming that an association with atopy is unlikely.
Furthermore, we analysed the genes SPINK6 and SPINK9, which
both code for epidermal protease inhibitors, in 15 patients.
No mutations were found in the exons and flanking intronic
regions of these genes (Table 3).
Discussion
This study showed that KE is a separate entity, characterized
by superficial collarette-like dry peeling of glabrous palmopl-
antar skin, which is definitely distinct from dyshidrotic
eczema, tinea, APSS and localized EBS. We prefer the term KE
rather than dyshidrosis lamellosa sicca, as the latter evokes an
association with dyshidrotic eczema, hyperhydrosis or eczema
in general, which we demonstrated in this study not to be the
case. ‘Keratolysis exfoliativa’ better describes the clinical
(a) (b)
(c) (d)
Fig 2. Cleavage in the stratum corneum in
keratolysis exfoliativa. Light microscopy shows
cleavage (asterisk) within the stratum
corneum (a; biopsy VII, bar = 80 lm) and
parakeratosis accompanied by a thinned
granular layer (b; biopsy IV, bar = 80 lm).
Electron microscopy shows partially degraded
corneodesmosomes (arrows) accompanied by
intercellular widening in the mid to upper
part of the stratum corneum (c and d; biopsy
IA, bar = 0Æ5 lm and biopsy IIIB,
bar = 125 nm, respectively).
 2012 The Authors
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phenomenon of exfoliative peeling due to keratolysis of the
stratum corneum.
The lesions in KE involved only palmoplantar skin, most
frequently the volar aspects of the fingers. The peeling was
preceded by air-filled blisters, which were never filled with
fluid. Skin lesions in KE began typically with an erythematous
ring bordering the imminent lesions. Our findings concerning
the clinical presentation of KE are in agreement with the
earlier literature.3,5
KE has often been described as essentially asymptom-
atic,5,6,8 although some authors report sensitiveness of the
peeled skin.9,10 This study demonstrated that slight pruritus or
a burning sensation may precede the peeling, as well as pain
in peeled areas, although an absence of subjective symptoms
was also found.
This study confirmed that friction and water contact may
aggravate KE.3,11 An explanation for this could be the disrup-
tion of the epidermal barrier by mechanical forces or soaking
of the skin.16 In addition, and similar to APSS and localized
EBS,13,17 KE worsens in warm weather in about half of the
patients. Also, palmar and ⁄or plantar hyperhidrosis has been
described as being associated with KE,9,11 yet this was seen in
only 11 of the 24 patients in this study. Thus, it remains
unclear whether palmoplantar hyperhidrosis and warm
weather are associated with KE. However, it seems plausible
that palmoplantar hyperhidrosis could have similar effects on
the skin as water contact, which may increase the pH of the
stratum corneum (loss of ‘acid mantle’) and therefore push
the balance towards desquamation, as an alkaline pH increases
serine protease activity enforcing premature corneodesmolysis
and thus impairing the stratum corneum cohesion.18
It has been suggested that KE is a subtype of dyshidrotic
eczema.11,12 However, dyshidrotic eczema is characterized by
pruritic fluid-filled vesicles mainly on the lateral aspects of the
fingers, the palms and occasionally on the soles.19 Based on
our data and previous reports,3,9 it appears that KE differs
from dyshidrotic eczema, as it is not pruritic nor vesicular. In
our patients, atopic diathesis does not appear to be associated
with KE, nor was the disease associated with filaggrin muta-
tions. In addition, none of the studied biopsies showed an in-
flammatory infiltrate, exocytosis of lymphocytes or acanthosis.
Therefore, this study also demonstrates that KE differs histo-
pathologically from dyshidrotic eczema and atopic derma-
titis.20










specific IgE Palmar Plantar TGM5 KRT5 ⁄14 FLG SPINK6 ⁄9
1 ) Normal ) NP ) No mutations NP No mutations No mutations
2 Eczema, asthma Normal ) NP NP No mutations No mutations No mutations No mutations
3 ) Normal ) ) ) NP NP No mutations No mutations
4 ) Normal ) NP NP NP NP No mutations No mutations
5 Allergic rhinitis Elevated + ) ) NP NP No mutations No mutations
6 Asthma, allergic
rhinitis
Elevated ) ) ) No mutations NP R501X No mutations
7 Asthma, allergic
rhinitis
Normal ) NP ) No mutations NP No mutations No mutations
8 ) Normal ) ) ) NP NP No mutations No mutations
9 ) Normal + ) ) NP NP No mutations No mutations
10 ) Normal ) ) ) No mutations NP No mutations No mutations
11 ) Normal ) ) ) NP NP No mutations No mutations
12 Eczema NP ) NP NP No mutations NP No mutations No mutations
13 ) NP ) NP NP NP NP NP NP
14 Allergic rhinitis Normal ) NP NP NP NP NP NP
15 ) NP ) NP NP NP NP NP NP
16 ) NP ) NP NP No mutations NP No mutations No mutations
17 ) NP ) NP NP NP NP NP NP
18 Allergic rhinitis NP ) NP NP NP NP NP NP
19 ) NP ) NP NP NP NP NP NP
20 ) NP ) NP NP NP NP NP NP
21 Allergic rhinitis Elevated ) ) ) NP NP No mutations No mutations
22 Eczema NP ) ) NP NP NP No mutations NP
23 Asthma, allergic
rhinitis
NP ) NP ) No mutations No mutations No mutations NP
24 ) NP ) ) ) No mutations NP NP No mutations
+, Positive; ), negative; NP, not performed.
 2012 The Authors
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It has been proposed that KE is a fungal infection3 or a der-
matophytid reaction caused by interdigital dermatomycosis of
the feet.8 Our findings demonstrated that KE is neither a fun-
gal infection nor a dermatophytid reaction (eczematide).
The histopathological hallmark of KE is clean cleavage
within the stratum corneum without a cellular infiltrate. Also,
parakeratosis with a thinned stratum granulosum was observed
possibly arising from enhanced keratinocyte proliferation. Fur-
thermore, the stratum corneum cleavage easily distinguishes
KE histopathologically from localized EBS, which is character-
ized by cytolysis in the basal layer.14 Histopathological differ-
entiation of KE from APSS may be more difficult, as the level
of blistering in APSS is located at the junction of the stratum
granulosum and the stratum corneum or within the stratum
corneum.13,17,21
In contrast to KE, fluid-filled blisters characterize localized
EBS and some cases of APSS, and both involve the dorsal
aspects in addition to the volar or plantar aspects of hands and
feet.14,21,22 In this study, molecular analysis of TGM5 and
KRT5 ⁄14 in doubtful cases excluded APSS and localized EBS,
respectively. In addition, KE appeared to be familial in a
minority of cases (six of 24, 25%), which keeps the possibil-
ity of a genetic cause open.
Degradation of corneodesmosomes at the upper stratum
corneum is a normal physiological process of desquamation to
maintain a constant thickness of the corneal layer by shedding
the outermost corneocytes at the skin surface.23 More interest-
ing is our observation that corneodesmosomes also degraded
in the middle part of the corneal layer. This finding suggests
premature corneodesmolysis, which may play a pivotal role in
the pathogenesis of KE.
We first examined deficiency of structural corneodesmoso-
mal components, such as corneodesmosin, desmocollin-1 and
desmoglein-1, which are associated with peeling skin disease,
staphylococcal scalded skin syndrome and palmoplantar kera-
toderma, respectively.24 However, immunofluorescence
microscopy in KE revealed normal staining for these compon-
ents.
Subsequently, we hypothesized that premature corneodesm-
olysis could be the result of an imbalance in the activity level
of enzymes involved in the desquamation process, specifically
in the palmoplantar skin.25 Furthermore, SPINK6 (serine prote-
ase inhibitor Kazal-type), encoding lymphoepithelial kazal-
type inhibitor (LEKTI)-3,26 and SPINK9, encoding LEKTI-2,27
are recently discovered serine protease inhibitors of kallikrein-
related peptidases (KLK) 5 ⁄7 ⁄14 and KLK5, respectively.
LEKTI-3 immune expression was found within the stratum
granulosum and stratum corneum of various anatomical sites
of the skin (face, arm, plantar site), sebaceous glands and
sweat glands, whereas LEKTI-2 immune expression was found
within the stratum granulosum and stratum corneum of
palmoplantar skin only. Activated KLK5, 7 and 14 can degrade
corneodesmosomal components.24 We selected SPINK6 ⁄9 as
candidate genes for KE, because we hypothesized that prema-
ture corneodesmolysis could be the result of increased activity





Fig 3. Normal expression of corneodesmosomal components in
keratolysis exfoliativa (KE). Analysis of (a) corneodesmosin (CDSN),
(b) desmocollin-1 (DSC1), (c) desmoglein-1 endodomain (DSG1-
B11) and (d) desmoglein-1 ectodomain (DSG1-P23) in skin sections
of patient no. 1. The images show a normal expression of
corneodesmosomal components in KE skin, which was similar to
control skin (not shown). Bar = 40 lm.
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protease inhibitors LEKTI-2 ⁄3. For example, in the case of
Netherton syndrome, which is characterized by ichthyosiform
dermatosis, hair shaft abnormality (trichorrhexis invaginata)
and atopic diathesis, mutations in SPINK5, encoding LEKTI,
cause unrestricted serine protease activity in the stratum cor-
neum resulting in overdesquamation of corneocytes.28,29 As
no mutations were found in SPINK6 ⁄9 in our patients with KE,
our theory of an imbalance between enzyme activity of serine
proteases and their inhibitors in the desquamation process
could not be demonstrated. However, it might be possible
that other proteases, such as cathepsins, which are also present
in human epidermis, are involved in the pathophysiology of
KE.
In summary, KE is a distinct entity characterized by cyclic
air-filled blisters and centrifugal collarette peeling of glabrous
digital, palmar and ⁄or plantar skin. Both sporadic and familial
cases were found. The histopathological and ultrastructural
characteristics are cleavage within the stratum corneum and
partial degradation of corneodesmosomes in the mid stratum
corneum, suggesting premature corneodesmolysis as the main
pathological mechanism in KE. However, immunofluorescent
staining showed normal expression of corneodesmosomal
components and no mutations were found in SPINK6 ⁄9.
Further studies in KE cases on other desquamation enzymes
and inhibitors, such as secretory leucocyte protease inhibitor
(SLPI), alpha-2 macroglobulin-like 1 (A2ML1), cholesterol
sulphate and zinc ion may shed more light on the possibly
genetic or acquired cause of this succinct dermatological
entity.30
What’s already known about this topic?
• Keratolysis exfoliativa also known as dyshidrosis lamell-
osa sicca was initially described a century ago, but has
almost been forgotten.
• This palmoplantar peeling disorder has been confused
with dyshidrotic eczema, dermatophytid reaction or
acral peeling skin syndrome.
What does this study add?
• Delineation of this distinct peeling entity, not related to
eczema, was carried out by studying the largest cohort
of 24 patients using modern laboratory techniques.
• Premature corneodesmolysis was found in the stratum
corneum. Mutations in TGM5, KRT5 ⁄14 and SPINK6 ⁄9
were excluded.
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